Kirk Trisler
Plus aucun poste en cours
Profil
Kirk Trisler worked as a Senior Director-Manufacturing Sciences at Geron Corp.
from 2009 to 2012, as a Director-Contract Manufacturing at Genitope Corp.
from 2005 to 2008, as a Radioimmunotherapy Director at Stanford University Hospital, as a Senior Development Scientist at Coulter Pharmaceuticals, Inc. and Corixa Corp.
Dr. Trisler also worked as a Vice President-Product Development at Asterias Biotherapeutics, Inc. from 2013 to 2014.
Dr. Trisler received his undergraduate and doctorate degrees from the University of South Florida.
Anciens postes connus de Kirk Trisler
| Sociétés | Poste | Fin |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Corporate Officer/Principal | 01/06/2014 |
| GERON CORPORATION | Corporate Officer/Principal | 01/01/2012 |
| GENITOPE CORPORATION | Corporate Officer/Principal | 01/01/2008 |
Stanford University Hospital
 Stanford University Hospital Hospital/Nursing ManagementHealth Services Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA. | Corporate Officer/Principal | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Formation de Kirk Trisler
| University of South Florida | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Entreprise privées | 5 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Stanford University Hospital
Stanford University Hospital Hospital/Nursing ManagementHealth Services Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA. | Health Services |